An Open-Label, Multicenter Study to Evaluate the Safety,

Project: Research project

Project Details

Description

An Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Three Dosing Regimens of Oral AT2220 in Patients with Pompe Disease
StatusFinished
Effective start/end date5/30/0812/31/10

Funding

  • Amicus Therapeutics

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.